Sami Alsaeed
Overview
Explore the profile of Sami Alsaeed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
79
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amara A, Trabelsi S, Hai A, Zaidi S, Siddiqui F, Alsaeed S
Pathogens
. 2025 Jan;
13(12.
PMID: 39770330
The COVID-19 infection caused by SARS-CoV-2 in late 2019 posed unprecedented global health challenges of massive proportions. The persistent effects of COVID-19 have become a subject of significant concern amongst...
2.
Kariri Y, Joseph C, Alsaleem M, Elsharawy K, Alsaeed S, Toss M, et al.
Cancers (Basel)
. 2022 Nov;
14(22).
PMID: 36428736
Background: Cell Division Cycle Associated 5 () plays a role in the phosphoinositide 3-kinase (PI3K)/AKT/mTOR signalling pathway involving cell division, cancer cell migration and apoptosis. This study aims to assess...
3.
Joseph C, Alsaleem M, Toss M, Kariri Y, Althobiti M, Alsaeed S, et al.
Cancers (Basel)
. 2021 Jan;
13(1).
PMID: 33396670
Background: The leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) plays a role in immune response homeostasis, extracellular matrix remodelling and it is overexpressed in many high-grade cancers. This study aimed to elucidate the...
4.
Kariri Y, Alsaleem M, Joseph C, Alsaeed S, Aljohani A, Shiino S, et al.
Breast Cancer Res Treat
. 2020 Oct;
185(2):293-305.
PMID: 33073304
Background: Lymphovascular invasion (LVI) is a prognostic factor in early-stage invasive breast cancer (BC). Through bioinformatics, data analyses of multiple BC cohorts revealed the positive association between interferon-stimulated gene 15...
5.
Kurozumi S, Alsaeed S, Orah N, Miligy I, Joseph C, Aljohani A, et al.
Breast Cancer Res Treat
. 2019 Nov;
179(3):557-564.
PMID: 31707510
Purpose: The epithelial-mesenchymal transition (EMT) plays a key role in breast cancer progression and metastasis. Lipocalin 2 (LCN2) is involved in the regulation of EMT. The aim of this study...
6.
Kurozumi S, Joseph C, Sonbul S, Alsaeed S, Kariri Y, Aljohani A, et al.
Br J Cancer
. 2019 May;
120(12):1129-1136.
PMID: 31114020
Background: Lymphovascular invasion (LVI) is associated with the development of metastasis in invasive breast cancer (BC). However, the complex molecular mechanisms of LVI, which overlap with other oncogenic pathways, remain...
7.
Kurozumi S, Joseph C, Raafat S, Sonbul S, Kariri Y, Alsaeed S, et al.
Breast Cancer Res Treat
. 2019 Apr;
176(1):63-73.
PMID: 30941650
Purpose: Androgen receptor (AR) and AR signaling pathways are thought to play a role in breast cancer (BC) and are potentially related to treatment responses and outcomes. Ankyrin 3 (ANK3)...
8.
Kurozumi S, Joseph C, Sonbul S, Aleskandarany M, Pigera M, Alsaleem M, et al.
Breast Cancer Res Treat
. 2018 Jul;
172(1):61-68.
PMID: 30056565
Background: Ras association and pleckstrin homology domains 1 (RAPH1) is involved in cytoskeleton regulation and re-epithelialisation in invasive carcinoma and, therefore, may play a key role in carcinogenesis and metastasis....